دورية أكاديمية

Hepatic resections for pediatric hepatoblastoma: analysis of 30-day outcomes using the National Surgical Quality Improvement Program-Pediatric database.

التفاصيل البيبلوغرافية
العنوان: Hepatic resections for pediatric hepatoblastoma: analysis of 30-day outcomes using the National Surgical Quality Improvement Program-Pediatric database.
المؤلفون: Thobani H; Section of Pediatric Surgery, Department of Surgery, Aga Khan University, Karachi, Pakistan.; Division of Pediatric Surgery, Department of Surgery, Stanford Center for Academic Medicine, Lucile Packard Children's Hospital, 453 Quarry Rd, Palo Alto, Stanford, CA, 94304, USA., Durrani R; Section of Pediatric Surgery, Department of Surgery, Aga Khan University, Karachi, Pakistan., Raymond SL; Division of Pediatric Surgery, Department of Surgery, University of Florida, Gainesville, FL, USA., Shah AA; Department of Pediatric Surgery, Children's Hospital and Medical Center, University of Nebraska, Omaha, NE, USA., Islam S; Section of Pediatric Surgery, Department of Surgery, Aga Khan University, Karachi, Pakistan., Khan FA; Division of Pediatric Surgery, Department of Surgery, Stanford Center for Academic Medicine, Lucile Packard Children's Hospital, 453 Quarry Rd, Palo Alto, Stanford, CA, 94304, USA. fakhan1@stanford.edu.
المصدر: Pediatric surgery international [Pediatr Surg Int] 2024 Aug 17; Vol. 40 (1), pp. 230. Date of Electronic Publication: 2024 Aug 17.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 8609169 Publication Model: Electronic Cited Medium: Internet ISSN: 1437-9813 (Electronic) Linking ISSN: 01790358 NLM ISO Abbreviation: Pediatr Surg Int Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Berlin : Springer International, c1986-
مواضيع طبية MeSH: Hepatoblastoma*/surgery , Liver Neoplasms*/surgery , Hepatectomy*/methods , Quality Improvement* , Postoperative Complications*/epidemiology , Databases, Factual*, Humans ; Female ; Infant ; Male ; Child, Preschool ; Child ; Treatment Outcome ; Retrospective Studies ; Blood Transfusion/statistics & numerical data ; United States
مستخلص: Background: Surgical resection remains the cornerstone of treatment for hepatoblastoma in children and offers the best chance of disease-free survival. We aimed to analyze the 30 day outcomes of hepatic resection for hepatoblastoma stratified by extent using the National Surgical Quality Improvement Program-Pediatric (NSQIP-P).
Methods: We queried NSQIP-P for children undergoing resection of Hepatoblastoma from 2012 to 2021. Relevant clinical characteristics and outcomes were extracted for multivariate logistic regression to identify predictors of common adverse outcomes.
Results: We included 458 children with a median age of 1.90 years. Overall complications were rare, and perioperative blood transfusion (64.2%) and postoperative ventilation > 48 h (10.0%) were the only adverse events prevalent in more than 5% of patients. Median transfusion volume was 15.7 ml/kg. On multivariate regression, only patients undergoing Trisectionectomy (aOR = 3.387, 95% C.I. = 1.348-8.510) had higher odds of receiving > 75th percentile blood transfusion. Furthermore, only perioperative transfusion and postoperative ventilation > 48 h were statistically more common in patients undergoing extended versus standard resections.
Conclusions: Outcomes following resection of hepatoblastoma are excellent, with low rates of postoperative adverse events. Although children undergoing trisectionectomy likely require greater transfusion volume, extended hepatic resections do not appear to have worse 30 day outcomes despite greater operative complexity and duration.
(© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
References: Cho SJ (2020) Pediatric Liver Tumors: Updates in Classification. Surg Pathol Clin [Internet]. 2020 Dec 1 [cited 2023 Oct 26];13(4):601–23. Available from: http://www.surgpath.theclinics.com/article/S1875918120300647/fulltext.
Meyers RL (2007) Tumors of the liver in children. Surg Oncol 16(3):195–203. (PMID: 10.1016/j.suronc.2007.07.00217714939)
Darbari A, Sabin KM, Shapiro CN, Schwarz KB (2003) Epidemiology of primary hepatic malignancies in US children. Hepatology 38(3):560–566. https://doi.org/10.1053/jhep.2003.50375. (PMID: 10.1053/jhep.2003.5037512939582)
Feng J, Polychronidis G, Heger U, Frongia G, Mehrabi A, Hoffmann K (2019) Incidence trends and survival prediction of hepatoblastoma in children: a population-based study. Cancer Commun 39(1):1–9. https://doi.org/10.1186/s40880-019-0411-7. (PMID: 10.1186/s40880-019-0411-7)
Kahla JA, Siegel DA, Dai S, Lupo PJ, Foster JH, Scheurer ME et al (2022) Incidence and 5 year survival of children and adolescents with hepatoblastoma in the United States. Pediatr Blood Cancer 10:e29763. https://doi.org/10.1002/pbc.29763. (PMID: 10.1002/pbc.29763)
Meyers RL, Maibach R, Hiyama E, Häberle B, Krailo M, Rangaswami A, et al. (2017) Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children’s Hepatic tumors International Collaboration. Lancet Oncol [Internet]. 2017 Jan 1 [cited 2023 Oct 26];18(1):122–31. Available from: http://www.thelancet.com/article/S1470204516305988/fulltext.
Tian Y, Chen X, Yu F, Feng J, Huang G, Ren X et al (2023) Neoadjuvant chemotherapy or upfront surgery in hepatoblastoma: a multicenter retrospective study. Pediatr Blood Cancer 70(9):e30470. https://doi.org/10.1002/pbc.30470. (PMID: 10.1002/pbc.30470)
Jha SK, Brown C, Kang L, Diaz ES, Gwal K, Alvarez E et al (2023) Update on the role of imaging in staging of common pediatric abdominal tumors. Curr Probl Cancer 47(2):100969. (PMID: 10.1016/j.currproblcancer.2023.10096937321909)
Cho SJ, Ranganathan S, Alaggio R, Maibach R, Tanaka Y, Inoue T et al (2023) Consensus classification of pediatric hepatocellular tumors: a report from the children’s hepatic tumors international collaboration (CHIC). Pediatr Blood Cancer. https://doi.org/10.1002/pbc.30505. (PMID: 10.1002/pbc.305053811080210546608)
Meyers RL, Czauderna P, Otte JB (2012) Surgical treatment of hepatoblastoma. Pediatr Blood Cancer. https://doi.org/10.1002/pbc.24220. (PMID: 10.1002/pbc.24220232554174304764)
Hafberg E, Borinstein SC, Alexopoulos SP. (2019) Contemporary management of hepatoblastoma. Curr Opin Organ Transplant [Internet]. 2019 Apr 1 [cited 2023 Oct 26];24(2):113–7. Available from: https://journals.lww.com/co-transplantation/fulltext/2019/04000/contemporary_management_of_hepatoblastoma.3.aspx.
Ortega JA, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Finegold MJ, et al. (2000) Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children’s Cancer Group and the Pediatric Oncology Group. J Clin Oncol [Internet]. 2000 Jul 21 [cited 2023 Oct 26];18(14):2665–75. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10894865.
Watanabe K (2013) Current chemotherapeutic approaches for hepatoblastoma. Int J Clin Oncol 18(6):955–961. https://doi.org/10.1007/s10147-013-0616-8. (PMID: 10.1007/s10147-013-0616-824052132)
Hiyama E (2014) Pediatric hepatoblastoma: diagnosis and treatment. Transl Pediatr 3(4):293. (PMID: 268353494728840)
Li P, Kong Y, Guo J, Ji X, Han X, Zhang B (2023) Incidence and trends of hepatic cancer among children and adolescents in the United States from 2000 to 2017: evidence from the surveillance, epidemiology, and end results registry data. Cancer Causes Control 34(1):69–79. https://doi.org/10.1007/s10552-022-01640-4. (PMID: 10.1007/s10552-022-01640-436244051)
Waters AM, Mathis MS, Beierle EA, Russell RT. (2019) A Synopsis of Pediatric Patients With Hepatoblastoma and Wilms Tumor: NSQIP-P 2012–2016. J Surg Res [Internet]. 2019 Dec 1 [cited 2023 Oct 26];244:338–42. Available from: https://pubmed.ncbi.nlm.nih.gov/31310947/.
Gupta H, Pant G, Verma N (2022) Malnutrition in childhood cancer patients: magnitude, key indicators and outcome. Pediatr Hematol Oncol J 7(4):155–160. (PMID: 10.1016/j.phoj.2022.09.001)
Litten JB, Tomlinson GE (2008) Liver tumors in children. Oncologist 13(7):812–820. https://doi.org/10.1634/theoncologist.2008-0011. (PMID: 10.1634/theoncologist.2008-001118644850)
Yang T, Whitlock RS, Vasudevan SA (2019) Surgical Management of Hepatoblastoma and Recent Advances. Cancers 2019, Vol 11, Page 1944 [Internet]. 2019 Dec 4 [cited 2023 Oct 26];11(12):1944. Available from: https://www.mdpi.com/2072-6694/11/12/1944/htm.
Moroz V, Morland B, Tiao G, Hiyama E, Kearns P, Wheatley K (2015) The paediatric hepatic international tumour trial (PHITT): clinical trial design in rare disease. Trials 16(Suppl 2):P224. (PMID: 10.1186/1745-6215-16-S2-P2244660185)
Sahinturk H, Ozdemirkan A, Zeyneloglu P, Torgay A, Pirat A, Haberal M (2019) Risk Factors for Postoperative Prolonged Mechanical Ventilation After Pediatric Liver Transplantation. Exp Clin Transplant [Internet]. 2019 May 14 [cited 2023 Oct 26];19(9):943–7. Available from: https://europepmc.org/article/med/31084587.
Nafiu OO, Carello K, Lal A, Magee J, Picton P (2017) Factors associated with postoperative prolonged mechanical ventilation in pediatric liver transplant recipients. Anesthesiol Res Pract 2017(1):8.
Xiao A, Feng Y, Yu S, Xu C, Chen J, Wang T, et al. (2022) General anesthesia in children and long-term neurodevelopmental deficits: A systematic review. Front Mol Neurosci [Internet]. 2022 Sep 27 [cited 2023 Oct 27];15. Available from: https://pubmed.ncbi.nlm.nih.gov/36238262/.
Lee JJ, Jaconia GD, Sun LS, Biagas K V., Naim MY, Beers SR, et al. (2023) Pediatric Intensive Care Unit Patients: Sedation, Monitoring, and Neurodevelopmental Outcomes. J Neurosurg Anesthesiol [Internet]. 2023 Jan 1 [cited 2023 Oct 27];35(1):147–52. Available from: https://journals.lww.com/jnsa/fulltext/2023/01000/pediatric_intensive_care_unit_patients__sedation,.27.aspx.
Goobie SM, DiNardo JA, Faraoni D (2016) Relationship between transfusion volume and outcomes in children undergoing noncardiac surgery. Transfusion [Internet]. 2016 Oct 1 [cited 2023 Oct 29];56(10):2487–94. Available from: https://pubmed.ncbi.nlm.nih.gov/27401674/.
Haeberle B, Rangaswami A, Krailo M, Czauderna P, Hiyama E, Maibach R, et al.(2020) The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children’s Hepatic tumors International Collaboration (CHIC) database. Pediatr Blood Cancer [Internet]. 2020 Aug 1 [cited 2023 Oct 29];67(8). Available from: https://pubmed.ncbi.nlm.nih.gov/32383794/.
Hu L, Li Z, Qiao Y, Wang A (2023) Does perioperative allogeneic blood transfusion worsen the prognosis of patients with hepatocellular carcinoma? A meta-analysis of propensity score-matched studies. Front Oncol [Internet]. 2023 [cited 2023 Oct 29];13. Available from: https://pubmed.ncbi.nlm.nih.gov/37854678/.
Bednarsch J, Czigany Z, Lurje I, Trautwein C, Lüdde T, Strnad P, et al.(2021) Intraoperative Transfusion of Fresh Frozen Plasma Predicts Morbidity Following Partial Liver Resection for Hepatocellular Carcinoma. J Gastrointest Surg [Internet]. 2021 May 1 [cited 2023 Oct 29];25(5):1212–23. Available from: https://pubmed.ncbi.nlm.nih.gov/32495137/.
Ye H, Wu H, Li B, Zuo P, Chen C (2023) Application of cardiovascular interventions to decrease blood loss during hepatectomy: a systematic review and meta-analysis. BMC Anesthesiol [Internet]. 2023 Dec 1 [cited 2023 Oct 29];23(1). Available from: https://pubmed.ncbi.nlm.nih.gov/36949393/.
Wisén E, Kvarnström A, Sand-Bown L, Rizell M, Pivodic A, Ricksten SE, et al. (2023) Argipressin for prevention of blood loss during liver resection: a study protocol for a randomised, placebo-controlled, double-blinded trial (ARG-01). BMJ Open [Internet]. 2023 Aug 24 [cited 2023 Oct 29];13(8). Available from: https://pubmed.ncbi.nlm.nih.gov/37620260/.
فهرسة مساهمة: Keywords: Children; Hepatectomy; Hepatic lobectomy; Hepatoblastoma; Pediatric liver tumors; Trisectionectomy
تواريخ الأحداث: Date Created: 20240817 Date Completed: 20240817 Latest Revision: 20240817
رمز التحديث: 20240818
DOI: 10.1007/s00383-024-05820-y
PMID: 39154089
قاعدة البيانات: MEDLINE
الوصف
تدمد:1437-9813
DOI:10.1007/s00383-024-05820-y